Linclatamig is a humanized antibody targeting the membrane-proximal epitope of LY6G6D. Linclatamig binds to CD3 with high affinity and exhibits potent antitumor activity both in vitro and in vivo. Linclatamig can be used for tumor research[1].
Molecular Weight:
(145.72 kDa)
Purity:
96.09
CAS Number:
[2885203-43-8]
Target:
CD3
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted